Add like
Add dislike
Add to saved papers

The application of fuzzy statistics and linear discriminant analysis as criteria for optimizing the preparation of plasma for matrix-assisted laser desorption/ionization mass spectrometry peptide profiling.

An alternative bioinformatics approach based on fuzzy theory statistics and linear discriminant analysis is proposed for the interpretation of MALDI MS spectra in peptide profiling. When applied, the methodology enables the establishment of a reproducible plasma preparation protocol appropriate for the evaluation of small data sets. The samples were collected from pregnant women affected by gestational diabetes mellitus (GDM), n=18 and control group, n=13. The following pre-treatment sets were tested: pipette tips with C18 stationary phase (ZipTip, Millipore and Omix, Agilent) and magnetic bead-based weak cation exchange chromatography kit (MB WCX, Bruker Daltonics). The spectra were recorded using a MALDI TOF mass spectrometer (UltrafleXtreme, Bruker Daltonics) for a mass range of m/z from 1000 to 10,000. The significant features were selected using the wrapper selection method, and two classification systems were tested: discriminant analysis (DA) and fuzzy inference system (FIS). ClinProTools software was employed to compare the usefulness of the proposed methodology. The study showed that the optimum results for MS spectra were obtained after the use of the ZipTip as pre-treatment method in plasma preparation. Chemometric analysis allowed the differentiation of the GDM group from the control with a high degree of accuracy: 0.7333 (DA) and 0.8065 (FIS).

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app